Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129

L. Badimon, E.L. Robinson, A. Jusic, I. Carpusca, L.J. DeWindt, C. Emanueli, P. Ferdinandy, W. Gu, M. Gyongyosi, M. Hackl, K. Karaduzovic-Hadziabdic, M. Lustrek, F. Martelli, E. Nham, I. Potocnjak, V. Satagopam, R. Schneider, T. Thum, Y. Devaux*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)1823-1840
Number of pages18
JournalCardiovascular Research
Volume117
Issue number8
DOIs
Publication statusPublished - 1 Jul 2021

Keywords

  • Artificial intelligence
  • Biomarkers
  • Genomics
  • RNAs
  • IMMUNE-RESPONSE
  • HEART-FAILURE
  • EUROPEAN-SOCIETY
  • BIOMARKERS
  • CELLULAR BIOLOGY
  • INFECTION
  • CARDIOPROTECTION
  • ASSOCIATION
  • SEVERITY
  • CARDIOLOGY WORKING GROUP

Cite this